Enhanced cardiac preconditioning in the isolated heart of the transgenic ((mREN-2)27) hypertensive rat

Cardiovascular Research

Volumn 33, Issue 2, 1997, Pages 400-409

  Randall, Michael D ^a   Gardiner, Sheila M ^a   Bennett, Terence ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

hypertension; myocardial ischemia; preconditioning; rat, heart; renin angiotensin aldosterone system; reperfusion; transgenic models

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HEART MUSCLE ISCHEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANTIHYPERTENSIVE AGENTS; BIPHENYL COMPOUNDS; HYPERTENSION; IMIDAZOLES; ISCHEMIC PRECONDITIONING, MYOCARDIAL; LOSARTAN; MALE; MYOCARDIAL ISCHEMIA; RATS; RATS, SPRAGUE-DAWLEY; RENIN-ANGIOTENSIN SYSTEM; TETRAZOLES;

EID: 0031033816     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(96)00210-6     Document Type: Article

References (40)

1. Murry C, Jennings R, Reimer K. Preconditioning with ischemia:a delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
2. Yellon DM, Alkhulaifi AM, Pugsley WB. Preconditioning in the human myocardium. Lancet 1993;342:276-277.
3. Ottani F, Galvani M, Ferrini D, et al. Prodromal angina limits infarct size: a role for ischemic preconditioning. Circulation 1995;91:291-297.
4. Lawson CS, Downey JM. Preconditioning: state of the art of myocardial protection. Cardiovasc Res 1993;27:542-550.
5. ATP channels in ischaemic preconditioning. Cardiovasc Res 1994;28:783-787.
6. Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145-H1152.
7. Mitchell MB, Meng X, Ao Lihua, Brown JM, Harken AH, Banerjee A. Preconditioning of isolated rat heart is mediated by protein kinase C. Circ Res 1995;76:73-81.
8. Hropot M, Grötsch H, Klaus E, et al. Ramipril prevents the detrimental sequels of chronic NO synthase inhibition in rats: hypertension, cardiac hypertrophy and renal insufficiency. Naunyn-Schmiedeberg's Arch Pharmacol 1994;350:646-652.
9. Kohya T, Yokoshiki H, Tohse N, et al. Regression of left ventricular hypertrophy prevents ischaemia-induced lethal arrhythmias: beneficial effect of angiotensin II blockade. Circ Res 1995;76:892-899.
10. Koyanagi S, Eastham CL, Harrison DG, Marcus ML. Increased size of myocardial infarction in dogs with chronic hypertension and left ventricular hypertrophy. Circ Res 1982;50:55-62.
11. Inou I, Lamberth WC, Koyanagi S, Harrison DG, Eastham CL, Marcus ML. Relative importance of hypertension after coronary occlusion in chronic hypertensive dogs with LVH. Am J Physiol 1987;253:H1148-H1158.
12. Speechly-Dick ME, Baxter GF, Yellon DM. Ischaemic preconditioning protects hypertrophied myocardium. Cardiovasc Res 1994;28:1025-1029.
13. Boutros A, Wang J. Ischemic preconditioning, adenosine and bethanechol protect spontaneously hypertensive isolated rat hearts. J Pharmacol Exp Ther 1995;275:1148-1156.
14. Mullins JJ, Peters J, Ganten D. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene. Nature 1990;344:541-544.
15. Bachmann S, Peters J, Engler E, Ganten D, Mullins J. Transgenic rats carrying the mouse renin gene - morphological characterization of a low-renin hypertension model. Kidney Int 1992;41:24-36.
16. Gardiner SM, March JE, Kemp PA, Mullins JJ, Bennett T. Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic (mRen-2)27, hypertensive rats. Br J Pharmacol 1995;116:237-2244.
17. Lee MA, Böhm M, Paul M, Bader M, Ganten U, Ganten D. Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27. Am J Physiol 1996;270:E919-E929.
18. McAinsh AM, Turner MA, O'Hare D, et al. Cardiac hypertrophy impairs recovery from ischaemia because of a reduced reactive hyperaemic response. Cardiovasc Res 1995;30:113-121.
19. Hiley CR, Yates MS. The distribution of cardiac output in the anaesthetized spontaneously hypertensive rats. Clin Sci Mol Med 1978;55:317-320.
20. Lee MA, Böhm M, Kim S, et al. Differential gene expression of renin and angiotensinogen in the TGR(mREN-2)27 transgenic rat. Hypertension 1995;25:570-580.
21. Böhm M, Lee MA, Kreutz R, et al. Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin-angiotensin-system gene expression and cardiovascular functions J Hypertens 1995;13:891-899.
22. Iwai N, Shimoike H, Kinoshita M. Cardiac renin-angiotensin system in the hypertrophied heart. Circulation 1995;92:2690-2696.
23. Liu Y, Tsuchida A, Cohen MV, Downey JM. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction isolated rabbits hearts. J Mol Cell Cardiol 1995;27:883-892.
24. Randall MD. The involvement of ATP-sensitive potassium channels and adenosine in the regulation of coronary flow in the isolated perfused rat heart. Br J Pharmacol 1995;116:3068-3074.
25. Randall MD, Greenhaff PL, Constantin-Teodosiu D. Dichloroacetate increases the threshold for cardiac preconditioning in the rat isolated perfused heart. Br J Pharmacol 1996;118:101P.
26. Takeo S, Liu J-X, Tanonaka K, et al. Reperfusion at reduced flow rates enhances postischemic contractile recovery of perfused heart. Am J Physiol 1995;268:H2384-2395.
27. Kelm M, Feelisch M, Krebber T, Deußen A, Motz W, Strauer BE. Role of nitric oxide in the regulation of coronary vascular tone in hearts from hypertensive rats: maintenance of nitric oxide-forming capacity and increased basal production of nitric oxide. Hypertension 1995;25:186-193.
28. Amezcua JL, Palmer RMJ, de Souza BM, Moncada S. Nitric oxide synthesized from L-arginine regulates vascular tone in the coronary circulation of the rabbit. Br J Pharmacol 1989;97:1119-1124.
29. Baker KM, Chemin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol 1990;259:H324-H332.
30. Gu X, Bishop SP. Increased protein kinase C and isozyme redistribution in pressure-overload cardiac hypertrophy in the rat. Circ Res 1994;75:926-931.
31. Schunkert H, Sadoshima JI, Cornelius T, et al. Angiotensin II-induced growth responses in isolated adult rat hearts: evidence for load-independent induction of calcium protein synthesis by angiotensin II. Circ Res 1995;76:489-497.
32. Anderson PG, Allard MF, Thomas GD, Bishop SP, Digerness SB. Increased ischemic injury but decreased hypoxic injury in hypertrophied rat hearts. Cire Res 1990;67:948-959.
33. Schönekess BO, Allard MF, Lopaschuk GD. Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. Circ Res 1995;77:726-734.
34. Raizada U, Pathak D, Avery G, Woodfin B. Accelerated glycolysis in early hypertensive left ventricular hypertrophy. Cardiology 1993;83:160-164.
35. Vanoverschelde J-LJ, Janier MF, Bakke JE, Marshall DR, Bergmann SR. Rate of glycolysis during ischemia determines extent of ischemic damage and functional recovery after reperfusion. Am J Physiol 1994;267:H1785-H1794.
36. Janier MF, Vanoverschelde J-LJ, Bergmann SR. Ischemic preconditioning stimulates anaerobic glycolysis in the isolated rabbit heart. Am J Physiol 1994;267:H1353-H1360.
37. Apstein CS, Morgan JP. In: Gaasch WH, Lewinter M, eds. Cellular Mechanisms of Diastolic Dysfunction: Implications for Therapy, Heart Failure and Left Ventricular Diastolic Function. Philadelphia, PA: Lea and Febiger, 1993;3-24.
38. Lasley RD, Anderson GM, Mentzer RM. Ischaemic and hypoxic preconditioning enhance postischaemic recovery of function in the rat heart. Cardiovasc Res 1993;27:565-570.
39. Cave AC, Horowitz GL, Apstein CS. Can ischemic preconditioning protect against hypoxia-induced damage? Studies on contractile function in isolated perfused rat hearts. J Mol Cell Cardiol 1994;26:1471-1486.
40. Allard MF, Flint JDA, English JC, et al. Calcium overload during reperfusion is accelerated in isolated hypertrophied rat hearts. J Mol Cell Cardiol 1994;26:1551-1563.